Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Increase

Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $79.00 by Analysts at Royal Bank of Canada

Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $79.00 by Analysts at Royal Bank of Canada

theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , United States , Blackrock , New Zealand General , New Zealand , Wellington , Lawrencej Hineline , Sureshk Durgam , , Royal Bank , Norges Bank , Cellular Therapies Inc , Morgan Stanley , Cantor Fitzgerald , Vanguard Group Inc , Wellington Management Group , Jpmorgan Chase Co , Needham Company , Blackrock Inc , Intra Cellular Therapies , Free Report , Moderate Buy , Cellular Therapies Stock Down , Cellular Therapies , Get Free Report , Management Group , Intra Cellular Therapies Daily ,